Your browser doesn't support javascript.
loading
Synthesis of 4-Tetrazolyl-Substituted 3,4-Dihydroquinazoline Derivatives with Anticancer Activity via a One-Pot Sequential Ugi-Azide/Palladium-Catalyzed Azide-Isocyanide Cross-Coupling/Cyclization Reaction.
Xiong, Jun; He, Hui-Ting; Yang, He-Yu; Zeng, Zhi-Gang; Zhong, Cheng-Ran; Shi, Hang; Ouyang, Meng-Ling; Tao, Yuan-Yuan; Pang, Yong-Long; Zhang, Yang-Hong; Hu, Bo; Fu, Zi-Xiang; Miao, Xiao-Lei; Zhu, Hai-Li; Yao, Gang.
Afiliação
  • Xiong J; School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, Hubei, P. R. China.
  • He HT; School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, Hubei, P. R. China.
  • Yang HY; School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, Hubei, P. R. China.
  • Zeng ZG; School of Nuclear Technology and Chemistry & Biology, Hubei University of Science and Technology, Xianning 437100, P. R. China.
  • Zhong CR; School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, Hubei, P. R. China.
  • Shi H; School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, Hubei, P. R. China.
  • Ouyang ML; School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, Hubei, P. R. China.
  • Tao YY; School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, Hubei, P. R. China.
  • Pang YL; School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, Hubei, P. R. China.
  • Zhang YH; School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, Hubei, P. R. China.
  • Hu B; School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, Hubei, P. R. China.
  • Fu ZX; School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, Hubei, P. R. China.
  • Miao XL; School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, Hubei, P. R. China.
  • Zhu HL; School of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, P. R. China.
  • Yao G; School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, Hubei, P. R. China.
J Org Chem ; 87(15): 9488-9496, 2022 08 05.
Article em En | MEDLINE | ID: mdl-35881945
A new one-pot preparation of 4-tetrazolyl-3,4-dihydroquinazolines has been reported. The Ugi-azide reactions of 2-azidobenzaldehydes, amines, trimethylsilyl azide, and isocyanides produced azide intermediates without separation, which were treated with isocyanides to give 4-tetrazolyl-3,4-dihydroquinazoline derivatives through a sequential Palladium-catalyzed azide-isocyanide cross-coupling/cyclization reaction in moderate to good yields. The biological evaluation demonstrated that compound 6c inhibited breast cancer cells well and displayed broad applications for synthesis and medicinal chemistry.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paládio / Cianetos Idioma: En Revista: J Org Chem Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paládio / Cianetos Idioma: En Revista: J Org Chem Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos